Search Results - "Cazorla, P"

Incorporating Ecosystem Functional Diversity into Geographic Conservation Priorities Using Remotely Sensed Ecosystem Functional Types by Cazorla, B. P., Cabello, J., Peñas, J., Garcillán, P. P., Reyes, A., Alcaraz-Segura, D.

“…Conservation biology must set geographic conservation priorities not only based on the compositional or structural but also on the functional dimensions of…”
Get full text

A remote-sensing-based dataset to characterize the ecosystem functioning and functional diversity in the Biosphere Reserve of the Sierra Nevada (southeastern Spain) by Cazorla, Beatriz P, Cabello, Javier, Reyes, Andrés, Guirado, Emilio, Peñas, Julio, Pérez-Luque, Antonio J, Alcaraz-Segura, Domingo

“…Conservation biology faces the challenge of safeguarding the ecosystem functions and ecological processes (the water cycle, nutrients, energy flow, and…”
Get full text

Impact of sodium glucose linked cotransporter‐2 inhibition on renal microvascular oxygen tension in a rodent model of diabetes mellitus by Hare, Gregory M. T., Zhang, Yanling, Chin, Kyle, Thai, Kerri, Jacobs, Evelyn, Cazorla‐Bak, Melina P., Nghiem, Linda, Wilson, David F., Vinogradov, Sergei A., Connelly, Kim A., Mazer, C. David, Evans, Roger G., Gilbert, Richard E.

“…Background The mechanisms whereby inhibitors of sodium‐glucose linked cotransporter‐2 (SGLT2) exert their nephroprotective effects in patients with diabetes…”
Get full text

Patterns of ecosystem functioning as tool for biological regionalization: the case of the Mediterranean-desert-tropical transition of Baja California by P. Cazorla, Beatriz, P. Garcillán, Pedro, Cabello, Javier, Alcaraz-Segura, Domingo, Reyes, Andrés, Peñas, Julio

“…Large-scale ecological variations across Earth have important consequences for biodiversity and, therefore, forbiological conservation. Despite the widespread…”
Get full text

P-214 - Incidence, onset and duration of treatment-emergent somnolence with asenapine in patients with schizophrenia or bipolar disorder by Cazorla, P, Zhao, J, Szegedi, A

“…Introduction & objective Assess the incidence and time-course of somnolence in placebo- and active-controlled asenapine schizophrenia and bipolar I disorder…”
Get full text

P.3.c.059 Incidence, onset, and duration of treatment-emergent somnolence with asenapine in adult patients with schizophrenia or bipolar disorder by Szegedi, A, Cazorla, P, Zhao, J

Get full text

P01-249-Weight change and metabolic effects of asenapine in placebo- or olanzapine-controlled studies by Zhao, J, Cazorla, P, Schoemaker, J, Mackle, M, Panagides, J, Karson, C, Szegedi, A

“…Introduction Weight change and metabolic effects of atypical antipsychotics vary considerably. Objective Assess weight and metabolic effects of asenapine in…”
Get full text

P03-340 - A pooled analysis of the effects of asenapine on the persistent negative symptoms of schizophrenia by Potkin, S.G, Phiri, P, Zhao, J, Alphs, L, Buchanan, R.W, Szegedi, A, Panagides, J, Cazorla, P

“…Introduction Asenapine and olanzapine reduced persistent negative symptoms (PNS) of schizophrenia in 2 double-blind, randomized 26-week studies and subsequent…”
Get full text

P03-341 - Meta-analysis of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other atypical antipsychotics by Szegedi, A, Verweij, P, van Duijnhoven, W, Mackle, M, Cazorla, P, Karson, C, Fennema, H

“…Introduction Asenapine is an FDA-approved atypical antipsychotic (AAP) indicated in adults for treatment of schizophrenia. Objective Present meta-analyses of…”
Get full text

48 – Psychometric evaluation of the Negative Symptom Assessment (NSA-16) scale in schizophrenic patients with predominant negative symptoms by Cazorla, P, Alphs, L, Hill, C, Stewart, M, Wilson, J, Morlock, R

Get full text

Prevalencia de parásitos intestinales en gallos de pelea de la Ciudad de Coro, Estado Falcón, Venezuela by Cazorla P, Dalmiro, Morales M, Pedro

“…En Venezuela, las peleas de gallos (Gallus gallus domesticus) representan una actividad recreacional importante y una fuente de empleo; sin embargo, su…”
Get full text

Effect of statins on mortality in patients with COVID-19: an updated meta-analysis of 147824 patients by Diaz-Arocutipa, C, Melgar-Talavera, B, Saravia-Bartra, M, Cazorla, P, Belzusarri, I, Alvarado-Yarasca, A, Hernandez, A V

Get full text

Integration of PZT thin films on a microfluidic complex system by Cazorla, P.-H, Fuchs, O., Cochet, M., Maubert, S., Le Rhun, G., Fouillet, Y., Defay, E.

“…We present a new way to integrate state of the art sol-gel Pb(Zr,Ti)O 3 (PZT) thin-films on a microfluidic system and the first peristaltic micropump with…”
Get full text

When to transfuse your acute care patient? A narrative review of the risk of anemia and red blood cell transfusion based on clinical trial outcomes by Hare, Gregory M. T., Cazorla-Bak, Melina P., Ku, S. F. Michelle, Chin, Kyle, Mistry, Nikhil, Sklar, Michael C., Pavenski, Katerina, Alli, Ahmad, Van Rensburg, Adriaan, Friedrich, Jan O., Baker, Andrew J., Mazer, C. David

“…This narrative review critically evaluates the evidence for risk of anemia and red blood cell (RBC) transfusion. For this purpose, it assesses large…”
Get full text

Renal microvascular oxygen tension during hyperoxia and acute hemodilution assessed by phosphorescence quenching and excitation with blue and red light by Chin, Kyle, Cazorla-Bak, Melina P., Liu, Elaine, Nghiem, Linda, Zhang, Yanling, Yu, Julie, Wilson, David F., Vinogradov, Sergei A., Gilbert, Richard E., Connelly, Kim A., Evans, Roger G., Baker, Andrew J., David Mazer, C., Hare, Gregory M. T.

“…Purpose The kidney plays a central physiologic role as an oxygen sensor. Nevertheless, the direct mechanism by which this occurs is incompletely understood. We…”
Get full text

1478O - Results of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain by Chow, L.Q., Barlesi, F., Bertino, E.M., van den Bent, M.J., Wakelee, H., Wen, P.Y., Chiu, C.-H., Orlov, S., Majem, M., Chiari, R., McKeage, M., Yu, C.-J., Hurtado, F.K., Arratia, P Cazorla, Song, Y., Branle, F., Shi, M., Kim, D.-W.

“…Ceritinib is approved for the treatment of pts with metastatic ALK+ NSCLC. In previous studies (ASCEND-1 to 5), ceritinib was highly active in ALK+ NSCLC pts…”
Get full text

Results of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain by Chow, L.Q., Barlesi, F., Bertino, E.M., van den Bent, M.J., Wakelee, H., Wen, P.Y., Chiu, C.-H., Orlov, S., Majem, M., Chiari, R., McKeage, M., Yu, C.-J., Hurtado, F.K., Arratia, P Cazorla, Song, Y., Branle, F., Shi, M., Kim, D.-W.

Get full text

1478OResults of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain by Chow, L Q, Barlesi, F, Bertino, E M, van den Bent, M J, Wakelee, H, Wen, P Y, Chiu, C-H, Orlov, S, Majem, M, Chiari, R, McKeage, M, Yu, C-J, Hurtado, F K, Arratia, P Cazorla, Song, Y, Branle, F, Shi, M, Kim, D-W

“…Abstract Background Ceritinib is approved for the treatment of pts with metastatic ALK+ NSCLC. In previous studies (ASCEND-1 to 5), ceritinib was highly active…”
Get full text

Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia by BUCHANAN, Robert W, PANAGIDES, John, CAZORLA, Pilar, JUN ZHAO, PHIRI, Phillip, DEN HOLLANDER, Wil, XIANWEI HA, KOUASSI, Alex, ALPHS, Larry, SCHOOLER, Nina, SZEGEDI, Armin

“…Two randomized, double-blind, 26-week core studies (Eastern [EH] and Western Hemisphere [WH]) tested the hypothesis that asenapine is superior to olanzapine…”
Get full text

PREVALENCIA DE PARÁSITOS INTESTINALES EN GALLOS DE PELEA DE LA CIUDAD DE CORO, ESTADO FALCÓN, VENEZUELA by Cazorla P., Dalmiro, Morales M., Pedro

Get full text